Subscribe to our newsletter

Atopic Dermatitis Registry

CorEvitas is now part of Thermo Fisher Scientific. Read More.

NOW ENROLLING

600 +
STUDY VISITS
1600 +
PATIENTS
70 +
DERMATOLOGISTS

Outcome measures in the CorEvitas AD Registry.

In addition to demographics, clinical features, medication history and changes, and comorbidities, key outcome measures collected include:

Clinician Reported Outcomes

Patient Reported Outcomes

Active safety assessments using structured data fields are collected with supporting documents to meet regulatory requirements and post marketing commitments of manufacturers.
Saturday September 7, 2019

Our Publications